Source of Information | Registry | Condition | Country | Mode of Administration | No of reminders | RR (%) at follow up points | Total follow up (years) | Change in RR (%/year) | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
t0 | t1 | t2 | t3 | t4 | t5 | ||||||||
Annual Report (2021) [41] | AOANJRR | Arthroplasty | Australia | Electronic | 1 | 66.7 | 61.5 | NA | NA | NA | NA | 0.5 | -10.5 |
Heo et al. (2019) [42], Churches et al. (2018) [43] | ACORN | Arthroplasty | Australia | Paper, phone | 7 | 86.4 | 74 | NA | NA | NA | NA | NA | NA |
Rolfson et al. (2011) [44] | WRHA Joint Replacement | Arthroplasty | Canada | Paper | 0 | 75 | NA | NA | NA | NA | NA | NA | NA |
Annual Report (2020–2021) [45] | VOTOR | Arthroplasty | Australia | Phone | NS | 85 | 80 | 76 | NA | NA | NA | 2 | -4.5 |
Annual Report (2022) [46] | Australian & New Zealand Hip Fracture Registry | Arthroplasty | Australia & New Zealand | NA | NA | NA | 53 | NA | NA | NA | NA | 1 | -12 |
Annual Report 2021–2022 [41] | Sydney Orthopaedic Foot & Ankle Research Institute Clinical Quality | Arthroplasty | Australia | NA | NA | 78 | 66 | NA | NA | NA | NA | 0.33 | NA |
Scholes et al. (2023) [47] | PRULO | Arthroplasty | Australia | NA | NA | 72 | NA | NA | NA | NA | NA | NA | NA |
Galea et al. (2020) [48] | DHAR | Arthroplasty | Denmark | Electronic | 2 | 70 | 62 | 68 | 68 | NA | NA | 2 | -1 |
Mechlenburg et al. (2020) [49] | DSR | Arthroplasty | Denmark | Electronic, paper | NS | 93 | NA | 62 | NA | NA | NA | 1 | -31 |
Rolfson et al. (2016) [50] | RIPO | Arthroplasty | Italy | Electronic | NS | 30 | NA | 80 | NA | NA | NA | 1 | 50 |
Rolfson et al. (2016) [50] | LAR | Arthroplasty | Lithuania | Phone | 0 | 100 | 60 | NA | NA | NA | NA | 0.5 | -80 |
Most et al. (2022) [51] | LROI | Arthroplasty | Netherlands | Electronic, paper | 0 | 38 | 50 | 38 | NA | NA | NA | 1 | 0 |
Rolfson et al. (2016) [50], Annual Report (2021) [24] | NZACL | Arthroplasty | New Zealand | Electronic, paper | > 1 | 100 | 86 | 80 | 86 | NA | NA | 2 | -7 |
Rolfson et al. (2016) [50], Annual Report (2021) [52] | NZJR | Arthroplasty | New Zealand | Paper | 0 | NA | 72.5 | NA | NA | NA | NA | 0.5 | NA |
Annual Report (2022) [53] | NAR | Arthroplasty | Norway | NS | NS | 98 | NA | 80 | NA | NA | NA | 1 | -18 |
Bartels et al. (2018) [54], Kristensen et al. (2017) [55], Gjertson et al. (2008) [56], Annual Report (2021) [57] | NHFR | Arthroplasty | Norway | Paper | 0 | 28.2 | 57 | 53 | NA | NA | NA | 1 | 24.8 |
Ulstein et al. (2018 ) [58], Annual Report (2021) [53] | NKLR | Arthroplasty | Norway | Paper | 1 | NA | NA | NA | 57.5 | 52.1 | 52 | 10 | NA |
Goh et al. (2021) [59] | Singapore Institutional Joint Registry | Arthroplasty | Singapore | NS | NS | 100 | 89 | NA | 72 | NA | NA | 2 | -14 |
SAR Annual Report (2021) [60] | SAR | Arthroplasty | Sweden | Electronic, paper | 1 | 85.5 | NA | 82.5 | NA | NA | NA | 1 | -3 |
Swedish Knee Ligament Register | Arthroplasty | Sweden | Electronic, paper | 1 | 60 | NA | 55 | 50 | 45 | 40 | 10 | -2 | |
Coster et al. (2020) [62] | Swefoot | Arthroplasty | Sweden | Electronic, Paper | 1 | 75 | NA | 72 | NA | NA | NA | 1 | -3 |
Joelson et al. (2021) [63] | Swespine | Arthroplasty | Sweden | Electronic, Paper | NS | 94 | NA | 75 | 65 | NA | NA | 2 | -14.5 |
Kamrad et al. (2017) [64] | SwedAnkle | Arthroplasty | Sweden | Paper | NS | NA | 55 | 76 | 30 | NA | NA | 2 | NA |
Geneva Hip Arthroplasty Registry | Arthroplasty | Switzerland | Electronic, paper, phone | 2 | 77 | NA | 65 | NA | 76.9 | 70.8 | 10 | -0.6 | |
Maempel (2018) [66], Annual Report (2022) [67] | NAHR | Arthroplasty | UK | Electronic, paper, phone | 2 | 96.5 | 50 | 40 | 7.5 | NA | NA | 2 | -44.5 |
Annual Report (2021) [68] | UK National Joint Registry | Arthroplasty | UK | Electronic, paper | 0 | 51.7 | 35 | NA | 11% | 29.9 | NA | 5 | -4.4 |
Annual Report (2015) [69] | UK NLR | Arthroplasty | UK | Electronic, paper | > 1 | 61.3 | 47 | 42 | 33 | NA | NA | 2 | -14.1 |
Patel et al. (2015) [70] | CJRR (California) | Arthroplasty | USA | Electronic, paper, phone | NS | 30.2 | 10 | 18.1 | NA | NA | NA | 1 | -11.9 |
Randsborg et al. (2022) [71] | HSS ACL Registry | Arthroplasty | USA | NS | NS | 31 | NA | NA | 31 | 51.2 | NA | 7.2 | 2.8 |
Lyman (2018) [72] | HSS Joint Replacement Registry | Arthroplasty | USA | Electronic | NS | 80 | NA | NA | 81 | NA | NA | 2 | 0.5 |
Annual Report (2021) [73] | AJRR | Arthroplasty | USA | Electronic, paper | NS | 25 | NA | 27.8 | NA | NA | NA | 1 | 2.8 |
Rolfson et al. (2016) [50] | FORCE TJR | Arthroplasty | USA | NS | NS | 82.5 | 82.5 | NA | NA | NA | NA | 0.5 | 0 |
Rolfson et al. (2016) [50] | Michigan Arthroplasty Registry | Arthroplasty | USA | NS | NS | 32 | 12 | NA | NA | NA | NA | 1 | -20 |
Annual Report (2020) [74] | PCOR-ANZ | Cancer | Australia | Electronic, paper, phone | NS | 57 | NA | 57% | NA | NA | NA | 1 | 0 |
PCOR-VIC | Cancer | Australia | Electronic, paper, phone | > 1 | 98.5 | NA | 75 | 75 | NA | NA | 2 | -11.8 | |
Annual Report (2020) [74] | PCOR-QLD | Cancer | Australia | Paper | NS | NA | 49 | NA | NA | NA | NA | 1 | NA |
Annual Report (2020) [74] | PCOR-ACT | Cancer | Australia | Electronic, paper, phone | NS | NA | 62 | NA | NA | NA | NA | 1 | NA |
Annual Report (2020) [74] | PCOR-NSW | Cancer | Australia | Electronic, paper, phone | NS | NA | 48 | NA | NA | NA | NA | 1 | NA |
Annual Report (2020) [74] | PCOR-NT | Cancer | Australia | Paper | NS | NA | 39 | NA | NA | NA | NA | 1 | NA |
Annual Report (2020) [74] | PCOR-NZ | Cancer | Australia | Electronic, paper | NS | NA | 68 | NA | NA | NA | NA | 1 | NA |
Annual Report (2020) [74] | PCOR-SA | Cancer | Australia | Paper | NS | NA | 33 | NA | NA | NA | NA | 1 | NA |
Annual Report (2020) [74] | PCOR-TAS | Cancer | Australia | Electronic, paper, phone | NS | NA | 44 | NA | NA | NA | NA | 1 | NA |
Ettridge et al. (2021) [75] | SAPCCOC Registry | Cancer | Australia | Paper | NS | NA | 75 | 60 | 57 | NA | NA | 2 | NA |
Skandarajah et al. (2021) [76] | VCR | Cancer | Australia | Paper | 1 | 45.6 | NA | 47.3 | 48.1 | 41.5 | NA | 5 | -0.8 |
Sztankay et al. (2019) [27] | aMYELOIDr | Cancer | Austria | Electronic | NS | 99 | 94 | NA | NA | NA | NA | NA | NA |
Vasquez et al. (2020) [77] | APCaRI Registry & Biorepository | Cancer | Canada | Electronic, paper | NS | 77 | NA | NA | NA | NA | NA | NA | NA |
Joachim et al. (2018) [78] | MCR | Cancer | Caribbean | Electronic, paper | 1 | 85 | NA | NS | NS | 70 | NA | 5 | NA |
Rose et al. (2020) [79] | DBCG Registry | Cancer | Denmark | Electronic | 1 | 60 | NA | NA | NA | 48.3 | NA | 5 | -2.3 |
Bronserud et al. (2019) [80] | DLCR | Cancer | Denmark | Electronic, paper | 2 | NA | 50.4 | 48.9 | NA | NA | NA | 1 | NA |
Nguyen-Nielsen et al. (2016) [81] | DAPROCAdata | Cancer | Denmark | Electronic, paper | NS | 26 | NA | 92 | NA | NA | NA | 1 | 66 |
Wallwiener et al. (2017) [82] | PRAEGNANT Register | Cancer | Germany | Electronic | 0 | 57 | 33 | NA | NA | NA | NA | 0.5 | 0 |
Lovegrove et al. (2020) [83] | HEAT Registry | Cancer | Global | Electronic | NS | 72.6 | 25.4 | NA | NA | NA | NA | NA | NA |
Gupta et al. (2021) [84] | PanCAN | Cancer | Global | Electronic | NS | 77.6 | NA | 75 | NA | NA | NA | 1 | -2.6 |
Van Kleef et al. (2021) [85] | NCR | Cancer | Netherlands | Electronic, paper | 0 | 85 | 14.8 | NA | NA | NA | NA | 0.02 | [Outlier] |
Ramsey et al. (2019) [86] | PROFILES Registry | Cancer | Netherlands | Electronic, paper | 1 | 73 | NA | 83 | 81.3 | NA | NA | 4 | 2 |
Christiansen et al. (2019) [87] | CRN | Cancer | Norway | Electronic | 1 | 97 | 91 | NA | NA | NA | NA | 0.3 | -24 |
Amit et al. (2019) [88] | Oropharynx Cancer Registry PROF Core | Cancer | USA | Paper | 1 | 84 | NA | NA | NA | NA | NA | NA | NA |
Hoffman et al. (2020) [23] | CaPSURE | Cancer | USA | Paper | NS | 100 | 97 | 94 | 85 | 77 | NA | 5 | -4.6 |
Barker et al. (2018) [89], Annual Report (2020) [90] | VCOR | Cardiac | Australia | Electronic, phone | 2 | NA | 72 | NA | NA | NA | NA | 0.08 | NA |
Ikemura et al. (2019) [25] | KiCS-AF registry (Cohort Study) | Cardiac | Japan | Electronic, paper | NS | 97 | NA | 91.7 | NA | NA | NA | 1 | -5.3 |
ORBIT-AF | Cardiac | USA | Electronic | NS | 94 | 80 | 67 | NA | NA | NA | 1 | -27 | |
Bradley et al. (2019) [92] | PALM Registry | Cardiac | USA | Electronic | 0 | 93 | NA | NA | NA | NA | NA | NA | NA |
Arnold et al. (2022) [93] | STS, ACC & TVT Registry | Cardiac | USA | NS | NS | 25 | 25 | NA | NA | NA | NA | 0.08 | 0 |
Annual report (2020–2021) [94] | VACAR | Cardiac | Australia | Phone | 3 | NA | 85 | NA | NA | NA | NA | 1 | NA |
Alarcon et al. (2020) [22] | COREXH Registry | Chronic Disease | Columbia | Paper | NS | 99 | 81 | 64 | NA | NA | NA | 1 | -35 |
Apfelbacher et al. (2019) [95] | CARPE | Chronic Disease | Germany | Electronic, paper | NS | NA | 87 | 69 | 49 | 22 | NA | NA | NA |
Kreuter et al. (2017) [96] | INSIGHTS-IPF Registry | Chronic Disease | Germany | Electronic | NS | 84.5 | 84.5 | NA | NA | NA | NA | 1 | NA |
Global NASH & NAFLD Registry | Chronic Disease | Global | Electronic | NS | 50 | NA | 14 | NA | NA | NA | 0.3 | -96 | |
Ahmed et al. (2015) [99] | CARE | Chronic Disease | Netherlands | Electronic, paper | 1 | 90 | 85 | NA | 82 | NA | NA | 2 | -4 |
Verket et al. (2018) [100] | ORAR | Chronic Disease | Norway | Paper | 0 | 71 | NA | NA | 75 | 59 | 61 | 15 | -0.7 |
Nimmo et al. (2018) [9] | SRR | Chronic Disease | Scotland | Paper | 0 | NA | 44 | NA | NA | NA | NA | NA | NA |
Mellgren et al. (2020) [101] | InfCareHiv | Chronic Disease | Sweden | Electronic, paper | 0 | NA | NA | 44 | NA | NA | NA | 1 | NA |
Svedbo (2018) [102] | Swedish NDR | Chronic Disease | Sweden | Paper | 1 | NA | 61 | NA | NA | NA | NA | NA | NA |
KLURING | Chronic Disease | Sweden | NS | NS | 100 | 76 | 90 | 72 | 49 | NA | 5 | -10.2 | |
Hofstedt et al. (2019) [105] | SRQ | Chronic Disease | Sweden | Electronic, paper | 0 | NA | 88 | NA | NA | NA | NA | NA | NA |
Twigg et al. (2017) [106] | YEAR | Chronic Disease | UK | Paper | NS | 92 | 74 | 74 | NA | NA | NA | 1 | -18.5 |
Callis Duffin et al. (2021) [107], Mease et al. (2017) [108], Strober et al. (2019) [109] | Corrona PsA, SpA Registry | Chronic Disease | USA | Paper | NS | NA | 99 | NA | NA | NA | NA | NA | NA |
Yun et al. (2020) [110] | Arthritis Power Registry | Chronic Disease | USA | Electronic | NS | NA | 33 | NA | NA | NA | NA | NA | NA |
Case et al. (2020) [111] | IPF-PRO Registry | Chronic Disease | USA | NS | NS | 76 | NA | NA | NA | NA | NA | NA | NA |
Braaten et al. (2019) [112] | UPI Arthritis Registry | Chronic Disease | USA | NS | NS | NA | 58 | NA | NA | NA | NA | NA | NA |
Feldon et al. (2017) [113] | MYOVISION | Chronic Disease | USA & Canada | Electronic, paper, phone | 1 | 91 | NA | NA | NA | NA | NA | NA | NA |
Zimmerman et al. (2019) [114] | Swedish National Quality Registry for Hand Surgery | General Surgery | Sweden | Electronic, paper | 0 | 33 | 27 | 24 | NA | NA | NA | 1 | -9 |
Hallenstal et al. (2021) [115] | NTSRS | General Surgery | Sweden | Electronic | 0 | NA | 44 | NA | NA | NA | NA | 0.5 | NA |
MBSC | General Surgery | USA | Electronic | 3 | 36 | 36 | NA | NA | NA | NA | 1 | 0 | |
Helsten et al. (2016) [118] | SATISFY-SOS Registry | General Surgery | USA | Electronic, paper, phone | 2 | NA | 62 | 71 | NA | NA | NA | 1 | NA |
Verket et al. (2018) [100] | Norwegian Endometriosis Association | Gynaecological Surgery | Norway | Paper | 0 | NA | 25 | 25 | NA | NA | NA | NA | NA |
Annual Report 2021 [119] | ABDR | General Surgery | Australia | NS | NS | NA | 40 | 40 | 38 | NA | NA | 5 | -0.2 |
Melkemichel (2020) [120], Lundstrom et al. (2018) [121], Jakobsson et al. (2022) [122] | SHR | Gynaecological Surgery | Sweden | Paper | 1 | NA | NA | 71 | NA | NA | NA | 1 | NA |
GynOp | Gynaecological Surgery | Sweden | Paper | 0 | NA | 90 | 85 | NA | NA | NA | 1 | NA | |
Bradley et al. (2021) [125] | PFDR-R | Gynaecological Surgery | USA | Electronic, paper | NS | 49 | NA | NA | NA | NA | NA | NA | NA |
Poulsen et al. (2018) [126] | National Patient Register | Miscellaneous | Denmark | Paper | 1 | NA | 79 | NA | NA | NA | NA | NA | NA |
CoULD Registry | Miscellaneous | Global | Electronic | 0 | NA | 97 | NA | NA | NA | NA | NA | NA | |
Ruiter et al. (2021) [129] | Dutch-Belgian Registry for NMJ Disorders | Miscellaneous | Netherlands & Belgium | Electronic | 0 | 88 | 49 | NA | NA | NA | NA | NA | NA |
Moller et al. (2022) [130], Lagergren et al. (2020) [131], Juto et al. (2017) [132] | SFR | Miscellaneous | Sweden | Paper | 1 | 55 | NA | 41 | NA | NA | NA | 1 | -14 |
Lutz et al. (2020) [133] | ATI Patient Outcomes Registry | Miscellaneous | USA | NS | NS | 54 | NA | NA | NA | NA | NA | NA | NA |
Pearl et al. (2020) [21] | ARMR | Miscellaneous | USA | Paper | 0 | 99.5 | NA | NA | NA | NA | NA | NA | NA |
Annual Report (2020–2021) [134] | ADNeT | Miscellaneous | Australia | Paper | 1 | 53 | NA | NA | NA | NA | NA | NA | NA |
Seefried et al. (2020) [20] | Global HPP Registry | Rare disease | Global | Electronic | NS | 68 | NA | NA | NA | NA | NA | NA | NA |
Morris et al. (2018) [19] | FSHD Patient Registry | Rare disease | UK | Electronic | 1 | NA | 89 | NA | NA | NA | NA | NA | NA |
Tosi et al. (2019) [16] | BBDC Contact Registry | Rare disease | USA | Electronic | NS | NA | 87 | NA | NA | NA | NA | NA | NA |
Eng et al. (2021) [18] | EBCare Registry | Rare disease | USA | Electronic | 0 | 19.5 | NA | NA | NA | NA | NA | NA | NA |
Annual Report (2022) [135] | ASR | Spine | Australia | Electronic, phone | 3 | 85 | 82 | 83 | 78 | NA | NA | 2 | -3.5 |
Andersen et al. (2018) [136] | DaneSpine | Spine | Denmark | Paper | 1 | 90 | NA | 86 | NA | NA | NA | 1 | -4.5 |
Matsumoto et al. (2021) [137] | PSSG & GSSG | Spine | Global | Electronic, paper | 0 | 42 | NA | 43 | 64.9 | NA | NA | 2 | 11.5 |
Mannion et al. (2018) [138], Morris et al. (2018) [19], Sunderland et al. (2021) [139] | EUROSPINE Spine Tango Registry | Spine | Global | Electronic, paper | 1 | 49 | 66 | 73.3 | 54 | NA | NA | 2 | 2.5 |
Austevoll et al. (2019) [140] | NORspine | Spine | Norway | Paper | 0 | NA | 79 | 81 | NA | NA | NA | 1 | NA |
Zakaria et al. (2019) [141] | MSSIC | Spine | USA | Electronic, paper, phone | 2 | 72 | 55 | 49 | NA | NA | NA | 1 | -23 |
Theisen et al. (2020) [142] | NBRG SCI Registry | Spine | USA | NS | NS | 92 | NA | NA | NA | NA | NA | NA | NA |
Wilkerson et al. (2022) [143] | NeuroPoint QOD | Spine | USA | NS | NS | 67 | 82 | 70 | NA | NA | NA | 1 | 2.6 |
Annual Report (2020) [144] | AuSCR | Stroke | Australia | Paper, phone | 2 | 92 | 65 | NA | NA | NA | NA | 0.5 | -54 |
Palmcrantz et al. (2018) [145] | RisStroke | Stroke | Sweden | Paper, phone | 0 | NA | 81 | 79 | NA | NA | NA | 1 | NA |
Turner et al. (2019) [146], Annual Report (2020–2021) [147] | BRANZ | Trauma | ANZ | Paper, phone | 4 | 71 | 55 | 40 | 21 | NA | NA | 2 | -25 |
Turner et al. (2019) [146] | VSTR | Trauma | Australia | Phone | NS | NA | 87 | 88 | 86 | NA | NA | 2 | NA |
PAIN OUT Infant | Trauma | Global | Electronic | NS | 20.6 | NA | NA | NA | NA | NA | NA | NA | |
Van der Vliet et al. (2019) [150] | DNTR | Trauma | Netherlands | Paper, phone | 2 | NA | 75 | 98 | NA | NA | NA | 1 | 23 |
Wihlke et al. (2021) [151] | SweTrau | Trauma | Sweden | Paper, phone | 1 | NA | 78 | 68 | NA | NA | NA | 1 | NA |
Kallman et al. (2020) [26] | SQRP | Trauma | Sweden | Electronic, paper | NS | 99 | 86 | 55 | NA | NA | NA | 1 | -44 |
Turner et al. (2019) [146] | TARN | Trauma | UK | Paper | NS | 61 | 88 | NA | NA | NA | NA | NA | NA |
Rolfson et al. (2011) [44] | CERTs Registry | Trauma | USA | NS | NS | 80 | NA | NA | NA | NA | NA | NA | NA |
FORTE project | Trauma | USA | Phone | NS | NA | 45 | 42 | NA | NA | NA | 1 | NA | |
Amtman et al. (2017) [153] | NIDILRR BMS National Database | Trauma | USA | Electronic, paper, phone | NS | 82 | 72 | 63 | 54 | NA | NA | 2 | -14 |